Dear Industry Colleagues,
On behalf of IATI and the Steering Committee of MIXiii Health-Tech.IL, we would like to welcome you to join us at MIXiii Health-Tech.IL conference and events to be held on the 7th and 8th November 2023 at the International Convention Center – ICC Jerusalem.
The healthtech industry has been experiencing dramatic changes due to the COVID-19 pandemic. From unique collaborations with players coming outside of the life sciences industry through fast paced adoption of digital health and remote health solutions, the pandemic had a huge impact on the industry. This also led to a record year when it comes to funding in 2021. The healthcare landscape is continuing to shift towards a more integrated ecosystem, converging biopharma, med-tech, digital and healthcare into a single bio-convergent industry. This emerging bio-convergent healthtech space holds great potential to make a transformative impact on health and healthcare practices. When it comes to holding a leading position in this emerging bio-convergent field, Israel has substantial strengths and capabilities.
As the Israel’s Umbrella Organization of the High-Tech & Life Science industries, IATI continuously acts to connect and promote the country’s massive resources of academic and technological prowess towards creating a fertile ecosystem which will nourish growth in the coming years as well.
MIXiii Health-Tech.IL conference will showcase all innovative trends and changes in the industry, and is a unique opportunity for all of us to meet and exchange knowledge, network and evolve our magnificent industry into the future.
Looking forward to seeing you at MIXiii Health-Tech.IL.
2022 MIXiii Health-Tech.IL Steering Committee
2022 Conference Main Topics
The conference will expose the latest developments within the healthcare and life science that emphasizes the synergy between bio-technology, engineering, technology and computerized systems.
The speakers at the event will include international top leaders in the Healthcare space coming from Google, AstraZeneca, Amazon, Teva, Amgen, McKinsey, Morgan Stanley, Ovid Therapeutics, Mayo Clinic, Cleveland clinic, Lumenis and more.